-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Maintains Neutral on Vicarious Surgical, Lowers Price Target to $7

Benzinga·08/13/2025 17:03:16
Listen to the news
Piper Sandler analyst Adam Maeder maintains Vicarious Surgical (NYSE:RBOT) with a Neutral and lowers the price target from $8.5 to $7.